Frontiers in Cardiovascular Drug Discovery: Volume 4

Volume in the series

Frontiers in Cardiovascular Drug Discovery

Publisher:Bentham Science

By: Atta-ur Rahman and M. Iqbal Choudhary

Paid access

|Apr 2019

E-Book €62.99Institutions €267.95

Frontiers in Cardiovascular Drug Discovery is an eBook series devoted to publishing the latest advances in cardiovascular drug design and discovery. Each volume brings reviews on the biochemistry, in-silico drug design, combinatorial chemistry, high-throughput screening, drug targets, recent important patents, and structure-activity relationships of molecules used in cardiovascular therapy. The eBook series should prove to be of great interest to all medicinal chemists and pharmaceutical scientists involved in preclinical and clinical research in cardiology.

The fourth volume of the series covers the following topics:

-Aspirin administration
-Adenosine receptor targeting for cardiovascular therapy
-Drug treatment of patients with coronary stenting
-Immunosuppressive drugs in heart transplantation
-PCSK9 inhibition for lowering LDL-C levels.

PDF ISBN: 978-1-68108-399-5

Publisher: Bentham Science

Publication date: 2019

Language: English

Pages: 215

Related subjects:

Medicine,

Clinical medicine,

Pharmacology, toxicology

Frontiers in Cardiovascular Drug Discovery: Volume 4

People also read

Publications carousel

Frontiers in Cardiovascular Drug Discovery: Volume 2

Frontiers in Cardiovascular Drug Discovery: Volume 3

Frontiers in Cardiovascular Drug Discovery: Volume 5

Frontiers in Cardiovascular Drug Discovery: Volume 6

Frontiers in Cardiovascular Drug Discovery: Volume 1

Advancements in Cardiovascular Research and Therapeutics: Molecular and Nutraceutical Perspectives

Frontiers in Drug Design and Discovery: Volume 12

Frontiers in Drug Design and Discovery: Volume 8

Frontiers in Drug Design and Discovery Volume: 11

Medicinal Chemistry of Drugs Affecting Cardiovascular and Endocrine Systems

Paradigm

My account